Published in Annu Rev Med on January 01, 1982
Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes. EMBO J (1997) 2.18
Lithium ion inhibits nerve growth factor-induced neurite outgrowth and phosphorylation of nerve growth factor-modulated microtubule-associated proteins. J Cell Biol (1985) 1.03
Effects of lithium ions on actin polymerization in the presence of magnesium ions. Biochem J (1991) 0.84
Tol1, a fission yeast phosphomonoesterase, is an in vivo target of lithium, and its deletion leads to sulfite auxotrophy. J Bacteriol (2000) 0.81
The influence of lithium chloride on experimental autoimmune thyroid disease. Clin Exp Immunol (1985) 0.75
Effectiveness of zinc in modulating lithium induced biochemical and behavioral changes in rat brain. Cell Mol Neurobiol (2007) 0.75
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry (1993) 9.09
Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry (1984) 4.72
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav (1980) 3.69
Light suppresses melatonin secretion in humans. Science (1980) 3.45
The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry (1988) 2.58
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) N Engl J Med (1988) 2.58
Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res (1979) 2.45
A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry (2001) 2.32
Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci (1983) 2.31
Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry (2000) 1.98
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N Engl J Med (1988) 1.95
Animal research versus humane use: the struggle to sustain our research advances. Interview by Edmund Kelly and Anthony Mazzaschi. FASEB J (1989) 1.94
Manic-depressive patients may be supersensitive to light. Lancet (1981) 1.91
Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry (1989) 1.89
Brain endolases as specific markers of neuronal and glial cells. Science (1978) 1.75
Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry (1982) 1.58
Disturbances of appetite and weight regulation in seasonal affective disorder. Ann N Y Acad Sci (1987) 1.56
Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry (1987) 1.55
Rates of seasonal affective disorder in children and adolescents. Am J Psychiatry (1995) 1.48
Exaggerated sensitivity to an organophosphate pesticide. Am J Psychiatry (1991) 1.46
Seasonality and affective illness. Am J Psychiatry (1989) 1.44
Plasma leptin in men and women with seasonal affective disorder and in healthy matched controls. Horm Metab Res (2005) 1.42
Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder. J Clin Psychiatry (1997) 1.40
The phototherapy light visor: more to it than meets the eye. Am J Psychiatry (1995) 1.38
Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry (1979) 1.33
Human aggression and suicide. Suicide Life Threat Behav (1986) 1.31
The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry (1973) 1.29
Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am J Psychiatry (1982) 1.28
Leukocytosis during lithium treatment. Am J Psychiatry (1971) 1.27
Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry (1987) 1.26
Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry (1988) 1.25
Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res (1990) 1.25
Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry (1973) 1.21
Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. Life Sci (1978) 1.20
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry (1982) 1.19
Relationship between sleep and mood in patients with rapid-cycling bipolar disorder. Psychiatry Res (1996) 1.19
Phototherapy of seasonal affective disorder. Time of day and suppression of melatonin are not critical for antidepressant effects. Arch Gen Psychiatry (1986) 1.19
Phase advance of the circadian sleep-wake cycle as an antidepressant. Science (1979) 1.16
Functional properties of neuronal and glial isoenzymes of brain enolase. J Neurochem (1978) 1.15
Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry (1985) 1.13
A rapid and sensitive radioreceptor assay for benzodiazepine in plasma. Arch Gen Psychiatry (1979) 1.11
Quantitative studies of norepinephrine uptake by synaptosomes. Biochem Pharmacol (1968) 1.11
Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res (1978) 1.10
The role of genetic factors in the etiology of seasonal affective disorder and seasonality. J Affect Disord (1999) 1.09
Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program. Am J Psychiatry (1996) 1.08
The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract (2001) 1.07
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biol Psychiatry (1970) 1.07
Effects of vasopressin on human memory functions. Science (1981) 1.07
Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem (1979) 1.07
Prediction of antidepressant responses to lithium. Am J Psychiatry (1978) 1.07
Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. Arch Gen Psychiatry (1975) 1.06
Developmental profile of neuron-specific (NSE) and non-neuronal (NNE) enolase. Brain Res (1980) 1.03
Blood platelets contain a neuron-specific enolase subunit. J Neurochem (1980) 1.03
Phototherapy in individuals with and without subsyndromal seasonal affective disorder. Arch Gen Psychiatry (1989) 1.03
Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry (1979) 1.03
Melatonin administration in insomnia. Neuropsychopharmacology (1990) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch Gen Psychiatry (1983) 1.02
Seasonal changes in mood and behavior. The role of genetic factors. Arch Gen Psychiatry (1996) 1.01
Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry (1987) 1.01
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
Heritable factors in the severity of affective illness. Biol Psychiatry (1976) 1.00
Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry (1979) 1.00
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
Evaluation of seasonality in six clinical populations and two normal populations. J Psychiatr Res (1991) 1.00
Seasonal affective disorders and phototherapy. Report of a National Institute of Mental Health-sponsored workshop. Arch Gen Psychiatry (1989) 1.00
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry (1998) 0.99
Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther (1982) 0.99
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia (1974) 0.98
Demonstration of an endogenous, competitive inhibitor(s) of [3H] diazepam binding in bovine brain. Life Sci (1978) 0.97
Effect of L-DOPA on depression. Lancet (1969) 0.97
Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects. Arch Gen Psychiatry (1980) 0.97
Neuroanatomical studies of major affective disorders. A review and suggestions for further research. Br J Psychiatry (1988) 0.96
Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients. Am J Psychiatry (1993) 0.96
Cholesterol levels in mood disorders: high or low? Bipolar Disord (2000) 0.96
Plasma DOPA response to levodopa administration in man: effects of a peripheral decarboxylase inhibitor. Clin Pharmacol Ther (1971) 0.95
Cerebrospinal fluid correlates of suicide attempts and aggression. Ann N Y Acad Sci (1986) 0.95
Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry (1998) 0.94
The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes. Arch Gen Psychiatry (1972) 0.93
Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study. Arch Gen Psychiatry (1989) 0.93
A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization. J Neurochem (1997) 0.93
48-hour sleep-wake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry (1982) 0.93
RBC membrane adenosine triphosphatase activities in patients with major affective disorders. Arch Gen Psychiatry (1983) 0.92
Sleep in fall/winter seasonal affective disorder: effects of light and changing seasons. J Psychosom Res (1994) 0.92
Treatment of seasonal affective disorder with light in the evening. Br J Psychiatry (1985) 0.92
Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry (1969) 0.92
Psychiatric side effects of levodopa in man. JAMA (1971) 0.91
Depressions following reserpine: a reevaluation. Semin Psychiatry (1971) 0.91
Insight and outcome in bipolar, unipolar, and anxiety disorders. Compr Psychiatry (2000) 0.91
Effect of lithium on the uptake of noradrenaline by synaptosomes. Nature (1967) 0.91
Structural and immunological properties of neuron specific protein (NSP) from rat, cat and human brain: comparison to bovine 14-3-2. J Neurochem (1977) 0.91
Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health. Am J Psychiatry (1981) 0.91
Topiramate treatment of bipolar spectrum disorders: a retrospective chart review. Ann Clin Psychiatry (2001) 0.91
Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter". Arch Gen Psychiatry (1981) 0.90
Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature (1971) 0.90
Purinergic inhibition of diazepam binding to rat brain (in vitro). Life Sci (1979) 0.90